A carregar...
Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently overexpressed...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5156841/ https://ncbi.nlm.nih.gov/pubmed/28018216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00466 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|